All Resources
Our resource hub to discover reports, policy papers and other forms of informative content
Search for Specific Brand Name Drug Negotiations Status with the pCPA
Use this tool to search for brand name drugs to view their current negotiation status….
Bluesky Project
Reimagining Canada’s Approval and Reimbursement System for Innovative Medicines February 2022…
Canadian public insurance plans and delays in patient access to innovative medicines
Canadians relying on public insurance plans face significant delays accessing new medicines. This graph breaks down the sequential approval and listing process, and demonstrates how long it takes Canadians to…
Addendum to IMC Submission on Drugs for Rare Diseases
Innovative Medicines Canada provides Health Canada with additional input regarding IMC’s March 2021 consultation submission on drugs for rare diseases….
Cost Drivers: Analysis of Private Drug Plans in Canada 2021
The 2021 Cost Drivers report highlights the consistent annual cost growth in the Canadian private drug benefits market and outlines factors that contribute to price increases….
